These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9526957)

  • 1. Platelet hypoaggregability in hereditary hypertriglyceridemic rats: relation to plasma triglycerides.
    Kunes J; Mazeaud MM; Devynck MA; Zicha J
    Thromb Res; 1997 Nov; 88(4):347-53. PubMed ID: 9526957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclic nucleotides in platelets of genetically hypertriglyceridemic and hypertensive rats. Thrombin and nitric oxide responses are unrelated to plasma triglyceride levels.
    Pernollet MG; Kunes J; Zicha J; Devynck MA
    Thromb Res; 2001 Oct; 104(1):29-37. PubMed ID: 11583736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different effects of endothelin-3 on the Ca2+ discharge induced by agonists and Ca(2+)-ATPase inhibitors in human platelets.
    Astarie-Dequeker C; Korichneva I; Devynck MA
    Br J Pharmacol; 1995 Jan; 114(2):524-30. PubMed ID: 7881751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell calcium handling and intracellular pH regulation in hereditary hypertriglyceridemic rats: reduced platelet response to thrombin stimulation.
    Zicha J; Kunes J; David-Dufilho M; Pernollet MG; Devynck MA
    Life Sci; 1996; 59(10):803-13. PubMed ID: 8761314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hepoxilin analog PBT-3 inhibits heparin-activated platelet aggregation evoked by ADP.
    Reynaud D; Hinek A; Pace-Asciak CR
    FEBS Lett; 2002 Mar; 515(1-3):58-60. PubMed ID: 11943194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired platelet aggregation and thromboxane generation in essential fatty acid-deficient rats.
    Takahashi R; Manku MS; Horrobin DF
    J Nutr; 1987 Sep; 117(9):1520-6. PubMed ID: 2888839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a novel non-carboxylic thromboxane A2 receptor antagonist (BM-531) derived from torasemide on platelet function.
    Dogné JM; de Leval X; Neven P; Rolin S; Wauters J; David JL; Delarge J; Massereel B
    Prostaglandins Leukot Essent Fatty Acids; 2000 May; 62(5):311-7. PubMed ID: 10883063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous prostaglandin endoperoxides may alter infarct size in the presence of thromboxane synthase inhibition: studies in a rabbit model of coronary artery occlusion-reperfusion.
    Golino P; Ambrosio G; Villari B; Ragni M; Focaccio A; Pace L; de Clerk F; Condorelli M; Chiariello M
    J Am Coll Cardiol; 1993 Feb; 21(2):493-501. PubMed ID: 8426016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local anesthetic effects on TXA2 receptor mediated platelet aggregation using quenched flow aggregometry.
    Honemann CW; Lo B; Erera JS; Polanowska-Grabowska R; Gear AR; Durieux M
    Adv Exp Med Biol; 1999; 469():269-76. PubMed ID: 10667341
    [No Abstract]   [Full Text] [Related]  

  • 10. Antiaggregatory effects of thromboxane receptor antagonists in vivo.
    Darius H; Lefer AM
    Thromb Res; 1985 Dec; 40(5):663-75. PubMed ID: 2935972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoaggregability of washed platelets from stroke-prone spontaneously hypertensive rats (SHRSP).
    Tomita T; Umegaki K; Hayashi E
    Stroke; 1984; 15(1):70-5. PubMed ID: 6420947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet hypersensitivity in cholesterol-fed rabbits: enhancement of thromboxane A2-dependent and thrombin-induced, thromboxane A2-independent platelet responses.
    Gross PL; Rand ML; Barrow DV; Packham MA
    Atherosclerosis; 1991 May; 88(1):77-86. PubMed ID: 1878012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that the rat is not an appropriate model to study the role of prostaglandins in normal or abnormal platelet aggregation.
    Huzoor-Akbar ; Anwer K
    Thromb Res; 1986 Feb; 41(4):555-66. PubMed ID: 3961734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testosterone increases human platelet thromboxane A2 receptor density and aggregation responses.
    Ajayi AA; Mathur R; Halushka PV
    Circulation; 1995 Jun; 91(11):2742-7. PubMed ID: 7758179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADP plays an important role in mediating platelet aggregation and cyclic flow variations in vivo in stenosed and endothelium-injured canine coronary arteries.
    Yao SK; Ober JC; McNatt J; Benedict CR; Rosolowsky M; Anderson HV; Cui K; Maffrand JP; Campbell WB; Buja LM
    Circ Res; 1992 Jan; 70(1):39-48. PubMed ID: 1727687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thromboxane (Tx) A2 receptor blockade and TxA2 synthase inhibition alone and in combination: comparison of anti-aggregatory efficacy in human platelets.
    Watts IS; Wharton KA; White BP; Lumley P
    Br J Pharmacol; 1991 Feb; 102(2):497-505. PubMed ID: 1826620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Labeling of human platelet plasma membrane thromboxane A2/prostaglandin H2 receptors using SQB, a novel biotinylated receptor probe.
    Komiotis D; Wencel-Drake JD; Dieter JP; Lim CT; Le Breton GC
    Biochem Pharmacol; 1996 Sep; 52(5):763-70. PubMed ID: 8765474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological characterization of potent, long-acting thromboxane receptor antagonists, SQ 33,261 and SQ 33,552.
    Harris DN; Michel IM; Goldenberg HJ; Hartl KS; Allen GT; Steinbacher TE; Schumacher WA; Han WC; Hall SE; Floyd DM
    J Pharmacol Exp Ther; 1992 Apr; 261(1):131-7. PubMed ID: 1532833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of thromboxane A2/prostaglandin H2 receptors of various tissues using a new radioiodinated thromboxane A2/prostaglandin H2 mimetic, I-BOP.
    Morinelli TA; Naka M; Masuda A; Oatis JE; Okwu AK; Mais DE; Saussy DL; Halushka PV
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():331-7. PubMed ID: 1825565
    [No Abstract]   [Full Text] [Related]  

  • 20. Antithrombogenic effects of calcium channel blockers: synergism with prostacyclin and thromboxane synthase inhibitors.
    Onoda JM; Sloane BF; Honn KV
    Thromb Res; 1984 Jun; 34(5):367-78. PubMed ID: 6377570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.